Powder: -20°C for 3 years
In solvent: -80°C for 2 years
SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis.
Description | SYP-5 is a novel inhibitor of HIF-1, suppresses tumor cells invasion and angiogenesis. |
In vitro | A novel HIF-1 inhibitor SYP-5 was first observed by the luciferase reporter assay.?Western blots results showed SYP-5 inhibited hypoxia-induced upregulation of HIF-1.?Moreover, the proteins of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP)-2 that are targets of HIF-1, were down-regulated by SYP-5.?Furthermore, in the tube formation assay, SYP-5 suppressed angiogenesis induced by hypoxia and VEGF in vitro.?Additionally, using Transwell and RTCA assays, we found that SYP-5 also retarded the Hep3B and Bcap37 cells migration and invasion induced by hypoxia and FBS.?Detected the upstream pathways related to HIF-1 and found both PI3K/AKT and MAPK/ERK were involved in the SYP-5 mediated invasive inhibition of Bcap37 cells.?SYP-5 inhibits tumor cell migration and invasion, as well as tumor angiogenesis, which are mediated by suppressing PI3K/AKT- and MAPK/ERK-dependent HIF-1 pathway.?It suggests that SYP-5 might be a potential HIF-1 inhibitor as an anticancer agent. |
Synonyms | SYP-5, Inhibitor, HIFs, Hypoxia-inducible factors, SYP5, inhibit, HIF-PH, SYP 5, HIF/HIF Prolyl-Hydroxylase |
Molecular Weight | 312.38 |
Formula | C18H16O3S |
CAS No. | 1384268-04-5 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 33.33 mg/mL (106.70 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.